Overview
Accelerated rejection of intestine transplant refers to an unusually rapid immune response leading to graft failure in intestinal transplantation, often necessitating prompt diagnostic and therapeutic interventions 1.Diagnosis
Elevated inflammatory markers (e.g., CRP, IL-6) indicative of acute rejection 1.
Histopathological examination showing characteristic signs of acute cellular rejection in biopsy samples 1.
Monitoring of clinical chemistry and hematology parameters for early detection of graft dysfunction 1.Management
Initiation of high-dose corticosteroids as first-line therapy to suppress immune response 1.
Adjunctive use of calcineurin inhibitors (e.g., tacrolimus) to modulate T-cell activity 1.
Consideration of anti-thymocyte globulin (ATG) or other lymphocyte-depleting agents in refractory cases 1.Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities related to accelerated rejection management in the given abstracts 1.Key Recommendations
Utilize clinical chemistry and hematology parameters for baseline comparison and early detection of accelerated rejection in baboon models (Evidence: Expert opinion) 1.
Employ high-dose corticosteroids as initial treatment for accelerated rejection to mitigate immune response (Evidence: Expert opinion) 1.
Incorporate calcineurin inhibitors like tacrolimus in management protocols to further control immune activity (Evidence: Expert opinion) 1.References
1 Schuurman HJ, Smith HT, Cozzi E. Reference values for clinical chemistry and clinical hematology parameters in baboons. Xenotransplantation 2004. link